Literature DB >> 15262345

Pathophysiology of preeclampsia: links with implantation disorders.

Philippe Merviel1, Lionel Carbillon, Jean-Claude Challier, Michèle Rabreau, Michel Beaufils, Serge Uzan.   

Abstract

The phenomenon of implantation anchors the embryo into the uterine wall and produces a hemochorial placenta that maintains the pregnancy and fetal growth. Implantation and placentation are intimately linked and cannot be dissociated either in time or in space. Preeclampsia is characterized by hypertension and proteinuria. It is secondary to an anomaly of the invasion of the uterine spiral arteries by extra-villous cytotrophoblast cells, associated with local disruptions of vascular tone, of immunological balance and inflammatory status, and sometimes with genetic predispositions. Preeclampsia is a disease of early pregnancy, a form of incomplete spontaneous abortion, but is expressed late in pregnancy. Aspirin may play a favorable role in implantation which is related to the genesis of preeclampsia and some cases of intra-uterine growth restriction. The most important points in obtaining a preventive effect from low-dose aspirin during the pregnancy are early treatment (before 13 weeks of gestation) and the prescription of a sufficient dose (more than 100 mg per day).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262345     DOI: 10.1016/j.ejogrb.2003.12.030

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  16 in total

1.  Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia.

Authors:  Lauretta A Lacko; Micol Massimiani; Jenny L Sones; Romulo Hurtado; Silvia Salvi; Sergio Ferrazzani; Robin L Davisson; Luisa Campagnolo; Heidi Stuhlmann
Journal:  Mech Dev       Date:  2014-04-19       Impact factor: 1.882

2.  Nitric oxide and carbon monoxide production and metabolism in preeclampsia.

Authors:  Robert M Ehsanipoor; Wilbert Fortson; Laura E Fitzmaurice; Wu-Xiang Liao; Deborah A Wing; Dong-Bao Chen; Kenneth Chan
Journal:  Reprod Sci       Date:  2012-09-25       Impact factor: 3.060

3.  Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta.

Authors:  Mauro Parra-Cordero; Cleofina Bosco; Jaime González; Rodrigo Gutiérrez; Pilar Barja; Ramón Rodrigo
Journal:  J Mol Histol       Date:  2011-08-17       Impact factor: 2.611

4.  Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice.

Authors:  Jeremy A Sandgren; Guorui Deng; Danny W Linggonegoro; Sabrina M Scroggins; Katherine J Perschbacher; Anand R Nair; Taryn E Nishimura; Shao Yang Zhang; Larry N Agbor; Jing Wu; Henry L Keen; Meghan C Naber; Nicole A Pearson; Kathy A Zimmerman; Robert M Weiss; Noelle C Bowdler; Yuriy M Usachev; Donna A Santillan; Matthew J Potthoff; Gary L Pierce; Katherine N Gibson-Corley; Curt D Sigmund; Mark K Santillan; Justin L Grobe
Journal:  JCI Insight       Date:  2018-10-04

5.  Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?

Authors:  Francesco Franceschi; Nicoletta Di Simone; Silvia D'Ippolito; Roberta Castellani; Fiorella Di Nicuolo; Giovanni Gasbarrini; Yoshio Yamaoka; Tullia Todros; Giovanni Scambia; Antonio Gasbarrini
Journal:  Helicobacter       Date:  2012-06-29       Impact factor: 5.753

6.  Previous abortions and risk of pre-eclampsia.

Authors:  Lill Trogstad; Per Magnus; Rolv Skjaerven; Camilla Stoltenberg
Journal:  Int J Epidemiol       Date:  2008-10-21       Impact factor: 7.196

7.  Novel piRNA Regulates PIWIL1 to Modulate the Behavior of Placental Trophoblast Cells and Participates in Preeclampsia.

Authors:  Jing Lin; Ye Zhou; Wei Gu
Journal:  Oxid Med Cell Longev       Date:  2022-04-14       Impact factor: 7.310

8.  Inhibitory Effect of the Punica granatum Fruit Extract on Angiotensin-II Type I Receptor and Thromboxane B2 in Endothelial Cells Induced by Plasma from Preeclamptic Patients.

Authors:  Widya Kusumawati; Kusnarman Keman; Setyawati Soeharto
Journal:  Adv Prev Med       Date:  2016-02-18

9.  The tyrosine phosphatase SHP-1 negatively regulates cytotrophoblast proliferation in first-trimester human placenta by modulating EGFR activation.

Authors:  Karen Forbes; Laura Skinner; John D Aplin; Melissa Westwood
Journal:  Cell Mol Life Sci       Date:  2012-07-15       Impact factor: 9.261

10.  The first trimester human trophoblast cell line ACH-3P: a novel tool to study autocrine/paracrine regulatory loops of human trophoblast subpopulations--TNF-alpha stimulates MMP15 expression.

Authors:  Ursula Hiden; Christian Wadsack; Nicole Prutsch; Martin Gauster; Ursula Weiss; Hans-Georg Frank; Ulrike Schmitz; Christa Fast-Hirsch; Markus Hengstschläger; Andy Pötgens; Angela Rüben; Martin Knöfler; Peter Haslinger; Berthold Huppertz; Martin Bilban; Peter Kaufmann; Gernot Desoye
Journal:  BMC Dev Biol       Date:  2007-12-19       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.